Pre Next

PDF Download

[1] QIAO Yan MU YiHE Fang MU Kefeng MU Ke MU Kexun YUAN Ruihua,.Preliminary Discussion on Clinical Medication Law of Taibai Herbaceous Medicine [J]. Journal of Shaanxi University of Traditional Chinese Medicine, 2021, (04): 21-26. [doi: 10.13424/j.cnki.jsctcm.2021.04.005]

Copy

Preliminary Discussion on Clinical Medication Law of Taibai Herbaceous Medicine

Journal of Shaanxi University of Traditional Chinese Medicine[ISSN: 2096-1340/ CN: 61-1501/R] Volumes & Issues: 2021 04 pagination: 21-26 Column: Publication date: 2021-07-30

Article number:: 2096-1340(2021)04-0021-06

Author(s):: QIAO Yan¹ MU Yi¹HE Fang² MU Kefeng¹ MU Ke³ MU Kexun¹ YUAN Ruihua⁴; 1.Yangling Renhe Hospital of Traditional Chinese Medicine，Shaanxi Yangling 712100，China; 2.Baoji Hospital of Traditional Chinese Medicine，Shaanxi Baoji 721300，China; 3.Yangling Maternal and Child Health and Family Planning Service Center，Shaanxi Yangling 712100，China; 4.Shaanxi University of Traditional Chinese Medicine，Shaanxi Xianyang 712046，China

Keywords:: Taibai herbal medicine; Eight methods; Adjuvants; Astringent drugs; Medicine team

ZTFLH:: R282

DOI:: 10.13424/j.cnki.jsctcm.2021.04.005

Code:: A

Abstract:: After thousands of years of inheritance and development，the clinical medication of Taibai herbal medicine has gradually formed a unique medication law.In clinical medication，it is often used “He Guan Ba Fa”，“skillful use of adjuvants”，“early use of astringent drugs”，“medicine with diversion” and “Mu Yi medicine team” to use drugs in accordance with the viscera and seasons.This paper makes a preliminary summary of its medication law，hoping to be corrected.

References:

［1］郑怀林,辛永洁,郑琪.太白山草药医学述略［J］.陕西中医,2001,22(6):381-382.
［2］李海宁.太白山北坡植物物种多样性及其垂直分布格局研究硕士学位论文［D］.西安:陕西师范大学,2007:9-10.
［3］孙涛,张岗,王继涛,等.太白山药用植物的中药药性与海拔相关性研究［J］.陕西中医药大学学报,2016,39(3):90-94.
［4］胡步超,申作洵.太白草医药考证及理论体系探讨［J］.中国民族民间医药杂志,1996，(5):1-2，46.
［5］老子.道德经［M］.山东:山东科学技术出版社，2008.
［6］王键,黄辉.中医学与中华传统文化(二)［J］.中医药临床杂志,2011,23(2):95-105.
［7］郭鹏,孔伟,王振国.和法的概念及其实质浅论［J］.山东中医药大学学报,2006，30(6):436-438,440.
［8］张晓雷,王玉光,沙茵茵,等.近现代医家对和法的认识及临床应用［J］.环球中医药,2016,9(11):1427-1432.
［9］徐姗姗,唐瑛,翟慕东.论八法皆可解表［J］.天津中医药,2006,23(4):306-308.
［10］黄帝内经素问［M］.北京：人民卫生出版,2012.
［11］米思嘉,王建萍.《临证指南医案》中治疗不寐的方药探析［J］.光明中医,2019,34(2):204-206.
［12］段阿里,鞠宝兆,王宏利,等.基于《黄帝内经》时脏相关理论的脏腑发病规律探讨［J］.中华中医药杂志,2019,34(10):4510-4513.
［13］钟霞,焦华琛,李运伦.《伤寒论》补土思想管窥［J］.辽宁中医药大学学报,2020,22(1):197-200.
［14］许慎著.汤可敬译注.说文解字［M］.北京：中华书局,2018.
［15］左传·襄公十年［M］.北京：中华书局,2016.
［16］汤小虎.基础方剂学研究进展［J］.中国中医基础医学杂志,2008,14(6):466-469.
［17］申明金,曹洪斌,陈丽.模糊聚类分析在收涩类中药研究中的应用［J］.中医药导报,2016,22(15):44-45，48.
［18］李时珍.本草纲目［M］.北京：中华书局,2016.
［19］王菲,范冬冬,魏鼎华,等.含乌头生物碱太白七药毒性研究［J］.陕西中医学院学报,2015,38(5):91-94.
［20］杨翠华.中药“药引”作用及用法浅析［J］.社区医学杂志,2011,9(1):47.
［21］尤怡.医学读书记［M］.北京：中国中医药出版社，2019.
［22］张叡.医学阶梯.［M］.北京：中国中医药出版社，2016.

Memo

基金项目：陕西省中医药管理局资助项目（2019-WT003，141020001）

Last Update: 2021-07-30